Chargement en cours...
The frequency of naïve and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse
Translation of therapeutic vaccines for addiction, cancer or other chronic non-communicable diseases has been slow because only a small subset of immunized subjects achieved effective antibody levels. We hypothesize that individual variability in the number of naïve and early-activated hapten-specif...
Enregistré dans:
| Publié dans: | J Immunol |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458396/ https://ncbi.nlm.nih.gov/pubmed/25972483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1500385 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|